Metis Global Partners LLC Increases Holdings in Ventas, Inc. $VTR

Metis Global Partners LLC lifted its holdings in Ventas, Inc. (NYSE:VTR) by 28.7% in the third quarter, HoldingsChannel reports. The fund owned 116,974 shares of the real estate investment trust’s stock after buying an additional 26,080 shares during the period. Metis Global Partners LLC’s holdings in Ventas were worth $8,187,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in VTR. NewEdge Advisors LLC increased its stake in shares of Ventas by 856.1% in the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after buying an additional 7,097 shares during the period. Empowered Funds LLC boosted its position in Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the period. Woodline Partners LP grew its holdings in Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after acquiring an additional 11,739 shares during the last quarter. Focus Partners Wealth increased its position in shares of Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares during the period. Finally, US Bancorp DE increased its position in shares of Ventas by 1.1% in the second quarter. US Bancorp DE now owns 23,375 shares of the real estate investment trust’s stock valued at $1,476,000 after acquiring an additional 256 shares during the period. Institutional investors own 94.18% of the company’s stock.

Insider Activity

In related news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Peter J. Bulgarelli sold 2,229 shares of the business’s stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $80.08, for a total value of $178,498.32. Following the transaction, the chief executive officer owned 106,488 shares of the company’s stock, valued at approximately $8,527,559.04. This trade represents a 2.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 96,868 shares of company stock valued at $7,574,022 in the last 90 days. Company insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Wells Fargo & Company upped their price target on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Cantor Fitzgerald reissued an “overweight” rating and set a $93.00 target price on shares of Ventas in a research note on Monday. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price target on shares of Ventas in a research note on Monday. Scotiabank lifted their price target on shares of Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a report on Thursday, November 13th. Finally, Argus set a $88.00 price objective on shares of Ventas in a report on Tuesday. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $85.38.

Ventas Stock Down 0.5%

NYSE:VTR opened at $85.26 on Friday. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.32 and a current ratio of 0.67. The firm has a market cap of $40.50 billion, a P/E ratio of 157.89, a P/E/G ratio of 2.09 and a beta of 0.77. Ventas, Inc. has a fifty-two week low of $60.08 and a fifty-two week high of $87.20. The firm has a 50-day simple moving average of $78.45 and a two-hundred day simple moving average of $73.68.

Ventas (NYSE:VTR) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period last year, the firm posted $0.81 EPS. Ventas’s quarterly revenue was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.52 per share. The ex-dividend date is Tuesday, March 31st. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. This is a boost from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio is 355.56%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.